ClinicalTrials.Veeva

Menu

Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Active, not recruiting

Conditions

Postural Tachycardia Syndrome

Treatments

Drug: Saline
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators will test whether an intravenous infusion of saline (salt water) will improve the exercise capacity in patients with postural tachycardia syndrome (POTS).

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meet diagnostic criteria of Postural Tachycardia Syndrome (POTS) 28
  • Age between 18-65 years
  • Male and female are eligible (although the majority of POTS patients are female).
  • Able and willing to provide informed consent

Exclusion criteria

  • Presence of medical conditions that can explain postural tachycardia (e.g., acute dehydration, medications)
  • Pregnancy
  • Other factors which in the investigator's opinion would prevent the subject from completing the protocol.
  • Patients who are bedridden or chair-ridden

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

40 participants in 2 patient groups, including a placebo group

Exercise Post Saline
Experimental group
Description:
Saline infusion 1L hours before exercise test
Treatment:
Drug: Saline
Placebo
Placebo Comparator group
Description:
Placebo given prior to exercise test
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems